Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

15.46
+2.0615.37%
Post-market: 15.45-0.0100-0.06%19:59 EDT
Volume:15.24M
Turnover:227.02M
Market Cap:3.12B
PE:-72.82
High:15.67
Open:13.69
Low:13.26
Close:13.40
52wk High:15.88
52wk Low:1.39
Shares:201.95M
Float Shares:199.00M
Volume Ratio:2.40
T/O Rate:7.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2123
EPS(LYR):-0.2463
ROE:-39.63%
ROA:-23.30%
PB:22.68
PE(LYR):-62.76

Loading ...

Are SELLAS Life Sciences (SLS) Loss Trends Masking a Shifting Cancer Vaccine Investment Narrative?

Simply Wall St.
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Decibel Cannabis Company (OtherDBCCF) and SELLAS Life Sciences Group (SLS)

TIPRANKS
·
Aug 21

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19

Sims (ASX:SGM) Shares Reprice After Profit Rebound Meets SLS Volatility

Simply Wall St.
·
Aug 18

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 14

Sellas Life Sciences Q2 Loss Narrows

MT Newswires Live
·
Aug 12

Earnings Flash (SLS) SELLAS Life Sciences Posts Q2 Loss $0.05, vs. FactSet Est of $0.05 Loss

MT Newswires Live
·
Aug 12

SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) Estimate

Benzinga Earnings
·
Aug 12

Sellas Life Sciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 12

Sellas Life Sciences Q2 Basic EPS USD -0.05

THOMSON REUTERS
·
Aug 12

Sellas Life Sciences Q2 Net Income USD -9.605 Million

THOMSON REUTERS
·
Aug 12

Press Release: Sellas Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 12

Sellas Net Loss Widens 45,51% to $ 9,61 Juta in Q2 FY26

Reuters
·
Aug 12

Canaccord Genuity Keeps Their Buy Rating on Solstice Minerals Limited (SLS)

TIPRANKS
·
Aug 04

Moderately bullish activity in Sellas Life Sciences with shares up 7.39%

TIPRANKS
·
Aug 03

Cboe data shows mixed options sentiment in Sellas Life Sciences with shares down 3.3%

TIPRANKS
·
Aug 01

Movement Alert|SELLAS Life Sciences Group Inc. Falls 8.63% in Regular Trading, All Arbitration Claims Dismissed

Market Focus
·
Jul 28

Moderately bullish activity in Sellas Life Sciences with shares down 11.17%

TIPRANKS
·
Jul 28

Sellas Life Sciences Group - Company to Pay About $1 Mln of 3D Medicines' Legal Fees - SEC Filing

THOMSON REUTERS
·
Jul 28

Sellas Life Sciences Group Inc: 3D Medicines Will Continue Development & Commercialization of Galinpepimut-S in Greater China Territory

THOMSON REUTERS
·
Jul 28